Year | Reference | Country | Age (years) | Sample size | IgAD (prevalence) | Criteria (g/L) |
---|---|---|---|---|---|---|
1970 | 229 | USA | 2.5–25 | 200 | 2 (1:100) | Undetectable |
1972 | 230 | USA | Children | 176 | 3 (1:59) | 0.2 |
1973 | 231 | Finland | 2–16 | 115 | 5 (1:23) | Undetectable |
1973 | 232 | USA | 1–21 | 200 | 8 (1:25) | 0.005 |
1977 | 233 | USA | Children | 324 | 14 (1:23) | 0.01 |
1979 | 234 | UK | Children | 582 | 12 (1:49) | 0.1 |
1983 | 235 | Finland | Children | 350 | 10 (1:35) | 0.02 |
2011 | 236 | Iran | Children | 83 | 1 (1:83) | NM |
Total for JRA | Â | Â | Â | 2,030 | 55 (1:37) | Â |
1969 | 53 | USA | NM | 61 | 1 (1:61) | Undetectable |
1971 | 237 | Norway | NM | 3187 | 8 (1:398) | Undetectable |
1985 | 57 | Turkey | NM | 25 | 1 (1:25) | NM |
1997 | 238 | India | 1–70 | 69 | 1 (1:69) | Undetectable |
2003 | 239 | UK | 18–75 | 352 | 8 (1:44) | <50 IU/mL |
Total for RA | Â | Â | Â | 3,694 | 19 (1:194) | Â |
Total | Â | Â | Â | 5,724 | 74 (1:77) | Â |